We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+22.23%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$18.5B
AUM Growth
+$2.83B
(+18%)
Cap. Flow
+$342M
Cap. Flow
% of AUM
1.85%
Top 10 Holdings %
Top 10 Hldgs %
16.55%
Holding
2,427
New
891
Increased
366
Reduced
546
Closed
599
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$163M |
| 2 |
Carnival Corporation Ltd
CCL
|
+$137M |
| 3 |
Repligen
RGEN
|
+$104M |
| 4 |
Biogen
BIIB
|
+$104M |
| 5 |
Zoetis
ZTS
|
+$91.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$173M |
| 2 |
Agilent Technologies
A
|
+$137M |
| 3 |
Fidelity National Information Services
FIS
|
+$86.2M |
| 4 |
Adobe
ADBE
|
+$76.2M |
| 5 |
Keurig Dr Pepper
KDP
|
+$75.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.24% |
| 2 | Consumer Discretionary | 12.89% |
| 3 | Financials | 10.77% |
| 4 | Technology | 9.62% |
| 5 | Industrials | 4.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Camtek
CAMT
$7.07B
| $292K | ﹤0.01% |
+13,157
| New | +$252K |
|
1652
Compass Diversified
CODI
$755M
| $291K | ﹤0.01% |
+14,948
| New | +$285K |
|
|
HI
1653
DELISTED
Hillenbrand
HI
| $291K | ﹤0.01% |
+7,328
| New | +$253K |
|
|
RAD
1654
DELISTED
Rite Aid Corporation
RAD
| $290K | ﹤0.01% |
+18,336
| New | +$236K |
|
1655
Thor Industries
THO
$3.98B
| $288K | ﹤0.01% |
3,094
-22,030
| -88% | -$2.06M |
|
1656
Itaú Unibanco
ITUB
$92.3B
| $286K | ﹤0.01% |
+64,488
| New | +$241K |
|
|
AGS
1657
DELISTED
PlayAGS
AGS
| $285K | ﹤0.01% |
39,649
-6,152
| -13% | -$28K |
|
1658
Resources Connection
RGP
$133M
| $284K | ﹤0.01% |
+22,585
| New | +$271K |
|
|
VIOT
1659
Viomi Technology
VIOT
$50.8M
| $284K | ﹤0.01% |
55,214
+25,275
| +84% | +$146K |
|
1660
Crown Castle
CCI
$32.4B
| $283K | ﹤0.01% |
+1,775
| New | +$288K |
|
|
BMY.RT
1661
CALL
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $283K | ﹤0.01% |
+410,558
| New | +$874K |
|
1662
Black Stone Minerals
BSM
$3.17B
| $282K | ﹤0.01% |
+42,173
| New | +$285K |
|
1663
Expeditors International
EXPD
$22.4B
| $280K | ﹤0.01% |
2,942
-156,254
| -98% | -$14.2M |
|
1664
Travelers Companies
TRV
$81.4B
| $279K | ﹤0.01% |
1,986
-4,331
| -69% | -$556K |
|
|
COUP
1665
DELISTED
Coupa Software Incorporated
COUP
| $278K | ﹤0.01% |
+821
| New | +$254K |
|
1666
Analog Devices
ADI
$181B
| $277K | ﹤0.01% |
+1,877
| New | +$249K |
|
|
YSG
1667
Yatsen Holding
YSG
$318M
| $276K | ﹤0.01% |
+3,251
| New | +$272K |
|
1668
Custom Truck One Source
CTOS
$2.44B
| $273K | ﹤0.01% |
+37,100
| New | +$188K |
|
1669
CEL-SCI Corp
CVM
$20.6M
| $273K | ﹤0.01% |
+781
| New | +$308K |
|
1670
Cenovus Energy
CVE
$52.3B
| $271K | ﹤0.01% |
+44,539
| New | +$208K |
|
|
BIG
1671
DELISTED
Big Lots, Inc.
BIG
| $271K | ﹤0.01% |
+6,320
| New | +$307K |
|
1672
Asana
ASAN
$1.79B
| $269K | ﹤0.01% |
+9,087
| New | +$232K |
|
1673
Boise Cascade
BCC
$2.75B
| $268K | ﹤0.01% |
5,602
-15,368
| -73% | -$668K |
|
|
ONCY
1674
Oncolytics Biotech
ONCY
$95.5M
| $268K | ﹤0.01% |
+112,594
| New | +$270K |
|
|
CDMO
1675
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $265K | ﹤0.01% |
+22,965
| New | +$210K |
|
Similar funds
Marshall Wace's Q4 2020 Portfolio in Review
As of Q4 2020, Marshall Wace held 2,427 positions worth $18.5B, up 18% from $15.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q4 2020 filing shows 891 new, 366 increased, 546 reduced and 599 closed positions. Its largest new stake was Natera: 911,254 shares worth $90.7M. The largest sale was Alphabet (Google) Class A, an estimated $173M.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
- Marshall Wace's largest Q4 2020 buy was Natera: 911,254 shares worth $90.7M.
- Marshall Wace added most to Thermo Fisher Scientific in Q4 2020, an estimated $163M increase.
- Marshall Wace's biggest Q4 2020 reduction was Alphabet (Google) Class A, cutting an estimated $173M.
- Marshall Wace fully exited FedEx in Q4 2020, selling an estimated $69.6M.
- Marshall Wace's ten largest holdings make up 17% of its $18.5B portfolio in Q4 2020.
- Marshall Wace opened 891 new positions and closed 599 in Q4 2020.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $18.5B.
Based on Marshall Wace's 13F filing for Q4 2020, filed 16 Feb 2021.